Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma

Lignende værker

• The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma
  af: Brayer, Jason, et al.
  Udgivet: (2017)
• Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
  af: Raedler, Lisa A.
  Udgivet: (2016)
• Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses
  af: Gupta, Neeraj, et al.
  Udgivet: (2017)
• Proteasome Inhibitors for the Treatment of Multiple Myeloma
  af: Ito, Shigeki
  Udgivet: (2020)
• Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
  af: Richardson, Paul G., et al.
  Udgivet: (2014)